CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma MicroenvironmentTomohiro Fujiwara, John H. Healey, Guangli Yang et al.|Molecular Cancer Therapeutics|2021Cited by 258
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancerKunitoshi Shigeyasu, Ajay Goel, Yoshinaga Okugawa et al.|JCI Insight|2018Cited by 148
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancerKazuya Kuwada, Toshiyoshi Fujiwara|Journal of Experimental & Clinical Cancer Research|2018Cited by 111
The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 associationYoichi Nagata, Mitsuyoshi Nakao, Tadashi Anan et al.|Oncogene|1999Cited by 101
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 AntibodyNobuhiko Kanaya, Toshiyoshi Fujiwara|Molecular Therapy|2020Cited by 77